⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL979977 | 0.78 | — | — | |
| SCHEMBL189745 | 0.68 | — | — | |
| SCHEMBL5495500 | 0.59 | — | — | |
| SCHEMBL7685523 | 0.59 | — | — | |
| SCHEMBL12236934 | 0.58 | — | — | |
| SCHEMBL18160865 | 0.58 | TSHR (0.30) | — | |
| SCHEMBL7094762 | 0.58 | KDM4E (0.33) | — | |
| SCHEMBL2183940 | 0.57 | — | — | |
| SCHEMBL14994705 | 0.57 | — | — | |
| SCHEMBL287041 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090305995-A1 | AGONISTS AND ANTAGONISTS OF THE SOMATOSTATIN RECEPTOR | NOVARTIS AG (CH) | 2009-12-10 | — | — | US | disclosed |
| EP-1814900-A1 | AGONISTS AND ANTAGONISTS OF THE SOMATOSTATIN RECEPTOR | Novartis AG (CH) | 2007-08-08 | — | — | EP | disclosed |
| WO-2006053700-A1 | AGONISTS AND ANTAGONISTS OF THE SOMATOSTATIN RECEPTOR | NOVARTIS AG (CH) | 2006-05-26 | — | — | WO | disclosed |